About Pharmahungary Group
Mission of Pharmahungary
- providing wide range of innovative and cost-effective preclinical pharmacology R&D services focusing on cardiovascular (infarction, heart failure, stroke, sepsis, arrhythmias, etc) and metabolic diseases (diabetes, dyslipidemia, atherosclerosis, obesity, uremia, etc) with strong scientific support
- clinical R&D services focusing on unique clinical studies including medical devices that need sensitive patient population and thereby strong regulatory & scientific support
- to manage internal R&D projects to develop new technologies for out-licensing in the fields of diagnosis and therapy of cardiovascular and metabolic diseases
Why Pharmahungary?
- Full service: creative, cost-effective, flexible, high quality
- 20 years experience in drug-development with many sucess stories
- Scientific support based on international scientific excellence (publications over 100, impact factors over 400, citations over 3500)
- Internationally trained management & staff (MDs, PhDs, clinical pharmacologists, PharmDs, chemists, biologists, medical engineers, MBA quality managers)
- Complex platforms of cardiovascular and metabolic disease models
- Custom design models with co-morbidities, including large animals
- Strong biochemical and molecular biological background for complex proof-of-concept studies
- Strict confidentiality, IP law of the European Union
